Issue: February 2017
February 08, 2017
1 min read
Save

Trial Scorecard: YELLOW II

Issue: February 2017
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers assessed changes in plaque morphology by IVUS in patients receiving high-intensity statin therapy.

Trial Scorecard: YELLOW II